Publication | Open Access
microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study
25
Citations
41
References
2021
Year
miR-221 expression was higher in tamoxifen-resistant BC cases. miR-221 is a potential biomarker of tamoxifen resistance.
| Year | Citations | |
|---|---|---|
Page 1
Page 1